{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:11:55Z","timestamp":1790115115116,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400846"],"award-info":[{"award-number":["82400846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274327"],"award-info":[{"award-number":["82274327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Grant from the Pingyuan Laboratory","award":["2023PYOP-0203"],"award-info":[{"award-number":["2023PYOP-0203"]}]},{"name":"Young Elite Scientists Sponsorship Program by CAST","award":["2023QNRC001"],"award-info":[{"award-number":["2023QNRC001"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7244407"],"award-info":[{"award-number":["7244407"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11596-025-00068-6","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T06:51:56Z","timestamp":1749624716000},"page":"626-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Crosstalk Between Th17 Cells and Renal Tubular Epithelial Cells Promotes Fibrotic Progression in IgA Nephropathy"],"prefix":"10.1007","volume":"45","author":[{"given":"Ye-na","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-kai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ru","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-lai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"1","key":"68_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, et al. IgA nephropathy. Nat Rev Dis Primers. 2023;9(1):67.","journal-title":"IgA nephropathy. Nat Rev Dis Primers."},{"issue":"1","key":"68_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","volume":"21","author":"CK Cheung","year":"2025","unstructured":"Cheung CK, Alexander S, Reich HN, et al. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2025;21(1):9\u201323.","journal-title":"Nat Rev Nephrol."},{"issue":"4","key":"68_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.kint.2018.02.030","volume":"94","author":"MK Saha","year":"2018","unstructured":"Saha MK, Julian BA, Novak J, et al. Secondary IgA nephropathy. Kidney Int. 2018;94(4):674\u2013681.","journal-title":"Kidney Int."},{"issue":"2","key":"68_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","volume":"104","author":"J Barratt","year":"2023","unstructured":"Barratt J, Lafayette RA, Zhang H, et al. IgA nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int. 2023;104(2):254\u2013264.","journal-title":"Kidney Int."},{"issue":"4","key":"68_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.kint.2024.06.023","volume":"106","author":"YL Chou","year":"2024","unstructured":"Chou YL, Chen HL, Hsu BG, et al. Galectin-3 contributes to pathogenesis of IgA nephropathy. Kidney Int. 2024;106(4):658\u2013670.","journal-title":"Kidney Int."},{"issue":"5","key":"68_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40265-024-02036-1","volume":"84","author":"L Del Vecchio","year":"2024","unstructured":"Del Vecchio L, Allinovi M, Comolli S, et al. Drugs in Development to Treat IgA Nephropathy. Drugs. 2024;84(5):503\u2013525.","journal-title":"Drugs."},{"issue":"4","key":"68_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.kint.2025.01.014","volume":"107","author":"J Floege","year":"2025","unstructured":"Floege J, Bernier-Jean A, Barratt J, et al. Treatment of patients with IgA nephropathy: a call for a new paradigm. Kidney Int. 2025;107(4): 640\u2013651.","journal-title":"Kidney Int."},{"issue":"5","key":"68_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/ard-2022-222495","volume":"82","author":"A Kronbichler","year":"2023","unstructured":"Kronbichler A, Bajema I, Geetha D, et al. Novel aspects in the pathophysiology and diagnosis of glomerular diseases. Ann Rheum Dis. 2023;82(5):585\u2013593.","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"68_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts C, Panzer U, Anders HJ, et al. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013;13(10):738\u2013753.","journal-title":"Nat Rev Immunol."},{"key":"68_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.intimp.2019.02.056","volume":"70","author":"L Bai","year":"2019","unstructured":"Bai L, Li H, Li J, et al. Immunosuppressive effect of artemisinin and hydroxychloroquine combination therapy on IgA nephropathy via regulating the differentiation of CD4+ T cell subsets in rats. Int Immunopharmacol. 2019;70:313\u2013323.","journal-title":"Int Immunopharmacol."},{"key":"68_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901465","volume":"13","author":"W Du","year":"2022","unstructured":"Du W, Gao CY, You X, et al. Increased proportion of follicular helper T cells is associated with B cell activation and disease severity in IgA nephropathy. Front Immunol. 2022;13:901465.","journal-title":"Front Immunol."},{"key":"68_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fcimb.2019.00151","volume":"9","author":"X Hu","year":"2019","unstructured":"Hu X, Feng J, Zhou Q, et al. Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses. Front Cell Infect Microbiol. 2019;9:151.","journal-title":"Front Cell Infect Microbiol."},{"key":"68_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.600598","volume":"12","author":"YM Zhang","year":"2021","unstructured":"Zhang YM, Liu XZ, Zhou XJ, et al. A Functional Variant rs3093023 in CCR6 Is Associated With IgA Nephropathy by Regulating Th17 Cells in a North Han Chinese Population. Front Immunol. 2021;12:600598.","journal-title":"Front Immunol."},{"issue":"1","key":"68_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.kint.2023.02.027","volume":"104","author":"GR Herrnstadt","year":"2023","unstructured":"Herrnstadt GR, Niehus CB, Ramcke T, et al. The CCR6\/CCL20 axis expands ROR\u03b3t+ Tregs to protect from glomerulonephritis. Kidney Int. 2023;104(1):74\u201389.","journal-title":"Kidney Int."},{"key":"68_CR15","doi-asserted-by":"publisher","first-page":"1425847","DOI":"10.3389\/fimmu.2024.1425847","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang J, Li X, Zhu Q, et al. Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis. Front Immunol. 2024;15:1425847.","journal-title":"Front Immunol."},{"issue":"5","key":"68_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/08830185.2024.2321901","volume":"43","author":"T Zhang","year":"2024","unstructured":"Zhang T, Huo H, Zhang Y, et al. Th17 cells: A new target in kidney disease research. Int Rev Immunol. 2024;43(5):263\u2013279.","journal-title":"Int Rev Immunol."},{"key":"68_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.916934","volume":"13","author":"J Qing","year":"2022","unstructured":"Qing J, Li C, Hu X, et al. Differentiation of T Helper 17 Cells May Mediate the Abnormal Humoral Immunity in IgA Nephropathy and Inflammatory Bowel Disease Based on Shared Genetic Effects. Front Immunol. 2022;13:916934.","journal-title":"Front Immunol."},{"issue":"1","key":"68_CR18","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1038\/s41598-024-55425-7","volume":"14","author":"MG Uriol-Rivera","year":"2024","unstructured":"Uriol-Rivera MG, Obrador-Mulet A, Juli\u00e1 MR, et al. Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients. Sci Rep. 2024;14(1):4866.","journal-title":"Sci Rep."},{"issue":"10","key":"68_CR19","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/j.ymthe.2023.07.024","volume":"31","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang M, Ren X, et al. Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury. Mol Ther. 2023;31(10):3067\u20133083.","journal-title":"Mol Ther."},{"issue":"2","key":"68_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.187653","volume":"10","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang Z, Wu Y, et al. RasGRP4 aggravates ischemia-reperfusion injury in diabetic kidneys by mediating communication between macrophages and T cells. JCI Insight. 2024;10(2):e187653.","journal-title":"JCI Insight."},{"issue":"1","key":"68_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills KHG. IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol. 2023;23(1):38\u201354.","journal-title":"Nat Rev Immunol."},{"issue":"11","key":"68_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41423-024-01218-x","volume":"21","author":"D Ohara","year":"2024","unstructured":"Ohara D, Takeuchi Y, Hirota K. Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells. Cell Mol Immunol. 2024;21(11):1183\u20131200.","journal-title":"Cell Mol Immunol."},{"key":"68_CR23","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.3389\/fimmu.2018.02385","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wang K, Liang X, et al. Complement C3 Produced by Macrophages Promotes Renal Fibrosis via IL-17A Secretion. Front Immunol. 2018;9:2385.","journal-title":"Front Immunol."},{"issue":"1","key":"68_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng X, Xiao Z, Zhang J, et al. IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol. 2015;235(1):79\u201389.","journal-title":"J Pathol."},{"issue":"6","key":"68_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00109-022-02201-7","volume":"100","author":"CC Lin","year":"2022","unstructured":"Lin CC, Chang TY, Lu YC, et al. TREM-2 mediates dendritic cell-induced NO to suppress Th17 activation and ameliorate chronic kidney diseases. J Mol Med (Berl). 2022;100(6):917\u2013931.","journal-title":"J Mol Med (Berl)."},{"issue":"4","key":"68_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357\u2013360.","journal-title":"Nat Methods."},{"issue":"7","key":"68_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621\u2013628.","journal-title":"Nat Methods."},{"issue":"3","key":"68_CR28","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.","journal-title":"Genome Biol."},{"issue":"3","key":"68_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33(3):290\u2013295.","journal-title":"Nat Biotechnol."},{"issue":"9","key":"68_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/nprot.2016.095","volume":"11","author":"M Pertea","year":"2016","unstructured":"Pertea M, Kim D, Pertea GM, et al. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11(9):1650\u20131667.","journal-title":"StringTie and Ballgown. Nat Protoc."},{"issue":"1","key":"68_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u2013140.","journal-title":"Bioinformatics."},{"issue":"11","key":"68_CR32","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust J, Sperl B, Hollis A, et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006;13(11):1235\u20131242.","journal-title":"Chem Biol."},{"issue":"13","key":"68_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111897","volume":"41","author":"FP Veras","year":"2022","unstructured":"Veras FP, Publio GA, Melo BM, et al. Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation. Cell Rep. 2022;41(13):111897.","journal-title":"Cell Rep."},{"issue":"2","key":"68_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ndt\/gfx246","volume":"33","author":"T Yokota","year":"2018","unstructured":"Yokota T, Omachi K, Suico MA, et al. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model. Nephrol Dial Transplant. 2018;33(2):214\u2013223.","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"68_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108723","volume":"9","author":"T Meng","year":"2014","unstructured":"Meng T, Li X, Ao X, et al. Hemolytic Streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells. PLoS One. 2014;9(9):e108723.","journal-title":"PLoS One."},{"issue":"1","key":"68_CR36","doi-asserted-by":"publisher","first-page":"2467235","DOI":"10.1080\/19490976.2025.2467235","volume":"17","author":"H Gao","year":"2025","unstructured":"Gao H, Sun M, Li A, et al. Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1\/Th17 cell apoptosis in inflammatory bowel disease. Gut Microbes. 2025;17(1):2467235.","journal-title":"Gut Microbes."},{"key":"68_CR37","doi-asserted-by":"publisher","first-page":"1522076","DOI":"10.3389\/fimmu.2024.1522076","volume":"15","author":"CC Deng","year":"2024","unstructured":"Deng CC, Xu XY, Zhang Y, et al. Single-cell RNA-seq reveals immune cell heterogeneity and increased Th17 cells in human fibrotic skin diseases. Front Immunol. 2024;15:1522076.","journal-title":"Front Immunol."},{"issue":"11","key":"68_CR38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158456","volume":"8","author":"KM Motz","year":"2023","unstructured":"Motz KM, Lina IA, Samad I, et al. Sirolimus-eluting airway stent reduces profibrotic Th17 cells and inhibits laryngotracheal stenosis. JCI Insight. 2023;8(11):e158456.","journal-title":"JCI Insight."},{"issue":"8","key":"68_CR39","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20090246","volume":"206","author":"EC Nowak","year":"2009","unstructured":"Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009;206(8):1653\u20131660.","journal-title":"J Exp Med."},{"issue":"7","key":"68_CR40","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1172\/JCI124037","volume":"130","author":"Y Salazar","year":"2020","unstructured":"Salazar Y, Zheng X, Brunn D, et al. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. J Clin Invest. 2020;130(7):3560\u20133575.","journal-title":"J Clin Invest."},{"issue":"4","key":"68_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","volume":"36","author":"W Elyaman","year":"2012","unstructured":"Elyaman W, Bassil R, Bradshaw EM, et al. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity. 2012;36(4):623\u2013634.","journal-title":"Immunity."},{"issue":"1","key":"68_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00281-016-0604-y","volume":"39","author":"W Elyaman","year":"2017","unstructured":"Elyaman W, Khoury SJ. Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol. 2017;39(1):79\u201387.","journal-title":"Semin Immunopathol."},{"key":"68_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139498","volume":"294","author":"J Shen","year":"2025","unstructured":"Shen J, Chen Y, Zhang Y, et al. Multifaceted roles of IL-17 in bone and tendon health. Int J Biol Macromol. 2025;294:139498.","journal-title":"Int J Biol Macromol."},{"key":"68_CR44","doi-asserted-by":"publisher","first-page":"1479505","DOI":"10.3389\/fimmu.2024.1479505","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li B, Lan T, et al. The role of interleukin-17 in inflammation-related cancers. Front Immunol. 2024;15:1479505.","journal-title":"Front Immunol."},{"key":"68_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110352","volume":"267","author":"MG Garc\u00eda-Pati\u00f1o","year":"2024","unstructured":"Garc\u00eda-Pati\u00f1o MG, Marcial-Medina MC, Ruiz-Medina BE, et al. IL-17 in skin infections and homeostasis. Clin Immunol. 2024;267:110352.","journal-title":"Clin Immunol."},{"key":"68_CR46","doi-asserted-by":"publisher","first-page":"1437046","DOI":"10.3389\/fimmu.2024.1437046","volume":"15","author":"MN Abdelnabi","year":"2024","unstructured":"Abdelnabi MN, Hassan GS, Shoukry NH. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease. Front Immunol. 2024;15:1437046.","journal-title":"Front Immunol."},{"issue":"5","key":"68_CR47","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3892\/or.2024.8803","volume":"52","author":"W Liu","year":"2024","unstructured":"Liu W, Wang X, Wu W. Role and functional mechanisms of IL\u201117\/IL\u201117R signaling in pancreatic cancer (Review). Oncol Rep. 2024;52(5):144.","journal-title":"Oncol Rep."},{"issue":"Pt 2","key":"68_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116598","volume":"230","author":"Q Liang","year":"2024","unstructured":"Liang Q, He L, Wang J, et al. Targeting IL-17 and its receptors: A feasible way for natural herbal medicines to modulate fibroblast-like synoviocytes in rheumatoid arthritis. Biochem Pharmacol. 2024;230(Pt 2):116598.","journal-title":"Biochem Pharmacol."},{"issue":"11","key":"68_CR49","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.chembiol.2006.11.001","volume":"13","author":"JS McMurray","year":"2006","unstructured":"McMurray JS. A new small-molecule Stat3 inhibitor. Chem Biol. 2006;13(11):1123\u20131124.","journal-title":"Chem Biol."},{"issue":"6","key":"68_CR50","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3892\/ijo.2016.3728","volume":"49","author":"L Lin","year":"2016","unstructured":"Lin L, Jou D, Wang Y, et al. STAT3 as a potential therapeutic target in ALDH+ and CD44+\/CD24+ stem cell-like pancreatic cancer cells. Int J Oncol. 2016;49(6):2265\u20132274.","journal-title":"Int J Oncol."}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-025-00068-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-025-00068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T08:02:56Z","timestamp":1751875376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-025-00068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s11596-025-00068-6","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"No human experimental protocol was established in this study. All animal experimental procedures adhered strictly to established animal welfare guidelines and were approved by the Cyagen Biosciences (Suzhou) Inc. the IACUC Committee (approval number: TACU24-FY069).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}